|
|
|
|
|
|
|
|
|
|
|
|
|
05.11.25 - 14:03
|
Establishment Labs Reports Third Quarter 2025 Financial Results (Business Wire)
|
|
|
NEW YORK--(BUSINESS WIRE)--Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women's health and wellness, principally in breast aesthetics and reconstruction, today announced financial results for the third quarter ended September 30, 2025.
Third Quarter Highlights and Outlook (Unaudited)
Third quarter worldwide revenue of $53.8 million, an increase of 33.8% from the year ago period. Revenue included $11.9 million of Motiva sales in the United States.
2025 revenue expected to exceed $210 million, an increase from previous guidance of $208 million to $212 million.
Third quarter gross margin of 70.1% compared to 63.9% in the year-ago period and 68.8% in the second quarter.
Third quarter loss from operations was $4.0 million compared to a loss of $13.1 million in the year-ago period and a loss of $14.1 million in the second quarter.
Third quarter Adjusted EBITDA was positive $1.2 million compared to a loss of $7.0 million in the year-ago period and a...
|
|
|
22.10.25 - 14:06
|
Establishment Labs to Announce Third Quarter 2025 Financial Results on November 5 (Business Wire)
|
|
|
NEW YORK--(BUSINESS WIRE)--Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women's health and wellness, principally in breast aesthetics and reconstruction, plans to announce its financial results for the quarter ended September 30, 2025, before the market opens on Wednesday, November 5, 2025, and will host a conference call at 8:30 am ET that day to discuss those results.
To participate in the conference call, dial (877) 407-8037 (U.S. and Canada) or +1 (201) 689-8037 (International) and use conference ID number 13750830. The call will also be available via live or archived webcast on the “Investor Relations” section of the Establishment Labs website at www.establishmentlabs.com.
About Establishment Labs
Establishment Labs Holdings Inc. is a global medical device company dedicated to improving women's health and wellness in breast aesthetics and reconstruction through the power of science, engineering, and technology. The Company offers a ...
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
07.08.25 - 14:06
|
Establishment Labs Reports Second Quarter 2025 Financial Results (Business Wire)
|
|
|
NEW YORK--(BUSINESS WIRE)--Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women's health and wellness, principally in breast aesthetics and reconstruction, today announced financial results for the second quarter ended June 30, 2025.
Second Quarter Highlights and Outlook (Unaudited)
Second quarter worldwide revenue of $51.3 million, an increase of 16.3% from the year ago period. Revenue included $10.3 million of Motiva sales in the United States.
2025 revenue guidance increased to $208 million to $212 million from $205 million to $210 million, year over year growth of 25%–28%, with at least $40 million in US Motiva revenue.
Second quarter gross margin of 68.8% compared to 65.6% in the year-ago period and 67.2% in the first quarter.
Second quarter loss from operations was $14.1 million compared to a loss of $9.3 million in the year-ago period and $16.9 million in the first quarter.
Second quarter adjusted EBITDA loss of $8.5 million compared t...
|
|
|
25.07.25 - 14:06
|
Establishment Labs to Announce Second Quarter 2025 Financial Results on August 7 (Business Wire)
|
|
|
NEW YORK--(BUSINESS WIRE)--Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women's health and wellness, principally in breast aesthetics and reconstruction, plans to announce its financial results for the quarter ended June 30, 2025, before the market opens on Thursday, August 7, 2025, and will host a conference call at 8:30 am ET that day to discuss those results.
To participate in the conference call, dial (416) 764 8646 (U.S. and Canada) or +1 (888) 396 8049 (International) and use conference ID number 13750829. The call will also be available via live or archived webcast on the “Investor Relations” section of the Establishment Labs website at www.establishmentlabs.com.
About Establishment Labs
Establishment Labs Holdings Inc. is a global medical device company dedicated to improving women's health and wellness in breast aesthetics and reconstruction through the power of science, engineering, and technology. The Company offers a portfoli...
|
|
|
|
|
|
|
24.04.25 - 14:03
|
Establishment Labs to Announce First Quarter 2025 Financial Results on May 7 (Business Wire)
|
|
|
NEW YORK--(BUSINESS WIRE)--Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women's health and wellness, principally in breast aesthetics and reconstruction, plans to announce its financial results for the quarter ended March 31, 2025, after the market closes on Wednesday, May 7, 2025, and will host a conference call at 4:30 pm ET that day to discuss those results.
To participate in the conference call, dial (877) 407-8037 (U.S. and Canada) or +1 (201) 689-8037 (International) and use conference ID number 13750827. The call will also be available via live or archived webcast on the “Investor Relations” section of the Establishment Labs website at www.establishmentlabs.com.
About Establishment Labs
Establishment Labs Holdings Inc. is a global medical device company dedicated to improving women's health and wellness in breast aesthetics and reconstruction through the power of science, engineering, and technology. The Company offers a portfolio...
|
|
|
10.04.25 - 15:03
|
Establishment Labs Provides Preliminary First Quarter Results and Announces an Investor Day on June 12 (Business Wire)
|
|
|
NEW YORK--(BUSINESS WIRE)--Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women's health and wellness, principally in breast aesthetics and reconstruction, provided preliminary first quarter 2025 sales results and announced that it will host an analyst and investor event in New York City on June 12, 2025.
Establishment Labs' preliminary unaudited revenue for the first quarter of 2025 is expected to be approximately $41.4 million, including approximately $6.2 million from Motiva sales in the United States.
On June 12, Establishment Labs' leadership team and invited plastic surgeons will present an update on the recent launch of Motiva in the United States, the company's innovation roadmap, and the financial outlook. A live and archived webcast of presentations and Q&A sessions on June 12 will be available on the "Investors" section of the Establishment Labs website at www.establishmentlabs.com. In-person attendance at the event is l...
|
|
|
|
Börsentreff auf Facebook |
Börsentreff auf X |
Börsentreff auf Instagram
